ARA-290 30mg is a nerve-support and inflammation-modulating peptide used where the goal is improved nerve comfort, better recovery support, and stronger alignment with neuropathic-pain and nerve-repair focused protocols. It is suited to those looking for a more structured option for nerve support, inflammatory modulation, and regenerative planning. Supplied as a 30mg cartridge in 3mL, it provides a pen-based format for repeated daily use.

How It Works

ARA-290, also known as cibinetide, is an erythropoietin-derived peptide designed for tissue-protective and innate-repair signalling without the red-blood-cell stimulating effects associated with erythropoietin. It is generally positioned for nerve support, inflammation modulation, and regenerative support rather than hematopoietic use.

In practical use, ARA-290 is usually chosen where the goal is support for neuropathic pain, nerve repair, inflammation control, and longer-term recovery-focused protocols. It is particularly relevant where nerve irritation, altered sensation, or inflammatory tissue stress are part of the picture.

Dosage Protocol

Neuropathic Pain / Nerve Repair: 2 - 4mg daily.
Inflammation Modulation: 1 - 2mg daily.
Aggressive Nerve Regeneration: 4 - 6mg daily.

Notes:
• Use 5 days per week with 2 days break over the weekend.
• Benefits build over weeks, with peak benefits often felt from weeks 2 - 3 and onwards.
• This 3mL version should be read against the 300-unit pen system.

Cycle length: For protocols 1 or 2, use for 6 - 12 weeks, then pause for 4 weeks before repeating if needed.
For protocol 3, use for 4 - 6 weeks, then pause for 4 weeks before repeating if needed.

Each cartridge contains 3mL bacteriostatic water (300 units)

Dosage scale with pen

KEEP REFRIGERATED.

Expected Outcomes

ARA-290 30mg is typically used where the goal is improved nerve comfort, better inflammatory control, and stronger regenerative support over time.

• Support for neuropathic pain-focused protocols
• Support for nerve repair and regeneration planning
• Improved alignment with inflammation-modulation goals
• Better fit within structured recovery-focused protocols
• Gradual benefit building over the first few weeks

Cautions and Warnings

Not suitable for people under the age of 18.
Not suitable during pregnancy.
Not suitable while breastfeeding.

Related Products

• BPC-157 — tissue-support pairing
• TB-500 — recovery-focused pairing
• KPV — useful where inflammatory skin or tissue support is a priority
• MOTS-C — metabolic and resilience support pairing